18.7 C
New York
Thursday, June 4, 2026

Tag: Ronald

newssourceFORcompanyinformationcontent1marketreleases

AbolerIS Pharma Presents New Data Supporting CD45RC as a Novel Therapeutic Target and Potential Biomarker in Sjögren’s Disease at EULAR 2026

- Findings demonstrate strong correlation between CD45RC expression and lymphocytic infiltration in salivary glands, supporting its potential as both an early biomarker and therapeutic...

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and...

COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update

COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq, while retaining the Company’s listing on the TSX

Made Scientific and New Jersey Delegates Celebrate Grand Opening of Flagship Cell Therapy Manufacturing Facility

New Jersey Department of Labor Commissioner Robert Asaro-Angelo, Assemblywoman Tennille McCoy, Plainsboro Township Mayor Edmund Yates, Middlesex County Board of Commissioners Director Ronald Rios,...

Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation (NASDAQ:NEOG), Alto Neuroscience, Inc. (NYSE:ANRO), RxSight, Inc. (NASDAQ:RXST), and Replimune Group, Inc. (NASDAQ:REPL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Step Inside McDonaldland VR: A Bold New Immersive World Featuring Grimace, Ronald McDonald, and Friends

CHICAGO, Aug. 11, 2025 /PRNewswire/ -- McDonald's is bringing its most iconic characters and worlds to life in an all-new way. Introducing McDonaldland VR —...

Famed Intellectual William F. Buckley Jr. Will Be Honored on a Stamp

WASHINGTON, Aug. 8, 2025 /PRNewswire/ --  ...

Home Genius Exteriors Donates $25,000 to Ronald McDonald House Charities of Greater Washington, D.C.

Employees also assemble over 1,000 care items as part of HGE Cares community impact initiative WASHINGTON, Aug. 8, 2025 /PRNewswire/ -- Home Genius Exteriors (HGE)...

Cathay Pacific Orders 14 More Boeing 777-9 Passenger Jets

HONG KONG, Aug. 6, 2025 /PRNewswire/ -- Boeing and Cathay Pacific today announced the Hong Kong-based carrier is ordering 14 more 777-9 passenger jets,...

Bragar Eagel & Squire, P.C. Is Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm

NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation (NASDAQ:NEOG), Alto Neuroscience, Inc. (NYSE:ANRO), RxSight, Inc. (NASDAQ:RXST), and Replimune Group, Inc. (NASDAQ:REPL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options

The Shareholders for Accountability of Lincoln Gold Mining Inc. Issue Information Circular for Upcoming Shareholders Meeting – Urge Shareholders to Read and Review the...

VANCOUVER, BC, July 31, 2025 /CNW/ - On July 31, 2025, a group of concerned shareholders of Lincoln Gold Mining Inc. ("LMG" or the...

Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation (NASDAQ:NEOG), Alto Neuroscience, Inc. (NYSE:ANRO), RxSight, Inc. (NASDAQ:RXST), and Replimune Group, Inc. (NASDAQ:REPL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

From Service to Support: Healing Veterans and Communities from the Opioid Crisis; Opioid Summit to be Held in Monroe, Louisiana

MONROE, La., July 28, 2025 /PRNewswire/ -- Northeast Delta Human Services Authority (NEDHSA) is set to host its 2025 Opioid Summit on Tuesday, August...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRonald

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers